Central Laboratory & Biomarker Testing Services

The contract pertains to the provision of central laboratory and biomarker testing services in support of clinical trials, with a focus on the processing and analysis of biological samples for biomarkers, pharmacokinetics, and safety-related endpoints. This subcontract is designated as a Total Small Business Set-Aside under the SBA program, ensuring that only small business concerns are eligible to compete, as defined by FAR 19.5. The procurement falls under NAICS code 541380, which categorizes it within other scientific and technical consulting services, specifically aligned with laboratory and analytical services for biomedical research. The contract is sponsored by the National Institute of Child Health and Human Development, a division of the U.S. Department of Health and Human Services, and is intended to support critical research activities across multiple clinical trial phases. The solicitation was posted on April 23, 2026, with a firm deadline for responses on June 10, 2026, at 8:30 PM Eastern Time. Although specific performance location details are not provided, the work is expected to be carried out at designated laboratory facilities meeting regulatory and scientific standards for clinical trial support. The nature of the services requires specialized expertise in sample handling, data integrity, and compliance with clinical research protocols to ensure the reliability and reproducibility of analytical results.